GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow


Phase N/A Results N/A

Summary of Purpose

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 November 2013.

1 Nov 2013 13 Nov 2013 1 Jun 2014 1 Dec 2014 1 Nov 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Basic Science
  • Endpoint: Pharmacodynamics Study
  • Intervention: Single Group Assignment